Johnson & Johnson joins Big Pharma's job-cutting parade - Daily Finance (blog)

Generic drug news

Boston Globe
Johnson & Johnson joins Big Pharma's job-cutting parade
Daily Finance (blog)
Generic competition to J&J's epilepsy drug Topamax and schizophrenia drug Risperdal was largely responsible for the fall. J&J has been cutting R&D costs, ...
Johnson & Johnson to axe 8190 global jobsTimes Online
J&J To Cut Up To 7% Of Work Force, Cites EconomyWall Street Journal
J & J to slash more than 7000 jobs in restructuringLos Angeles Times
Dividend.com (blog) -ABC News -Middle East North Africa Financial Network
all 402 news articles »